HIMX [Himax Technologies] 6-K: (Original Filing)

[Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides First Quarter 2016 Guidance Company Beats Q4 2015 Revenue, Gross Margin and EPS Guidance Provides First Quarter 2016 Guidance Revenue to be Down 1% to Up 4% Sequentially, Gross Margin to be Around 25%, and GAAP EPS per ADS to be 5.5 to 7.5 Cents Net] [Form 6-K 000-51847 Himax Technologies, Inc. No.26, Zilian Road, Xinshi Dist., Note: Note: Himax Technologies, Inc. Jackie Chang Chief Financial Officer 6-K 1 f6k_020416.htm FORM 6-K]

By | 2016-03-15T22:32:25+00:00 February 4th, 2016|Categories: Chinese Stocks, HIMX, SEC Original|Tags: , , , , , |0 Comments

HIMX [Himax Technologies] 6-K: Himax Technologies, Inc. Reports Fourth Quarter and Full

[Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides First Quarter 2016 Guidance Company Beats Q4 2015 Revenue, Gross Margin and EPS Guidance Provides First Quarter 2016 Guidance Revenue to be Down 1% to Up 4% Sequentially, Gross Margin to be Around 25%, and GAAP EPS per ADS to be 5.5 to 7.5 Cents Net] [Form 6-K 000-51847 Himax Technologies, Inc. No.26, Zilian Road, Xinshi Dist., Note: Note: Himax Technologies, Inc. Jackie Chang Chief Financial Officer 6-K 1 f6k_020416.htm FORM 6-K]

By | 2016-03-15T22:34:53+00:00 February 4th, 2016|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Receipt of Competing Non-Binding “Going Private” Proposal The special committee of the Company’s independent directors, which was formed to consider the preliminary non-binding proposal letter, dated January 30, 2016, from Mr. Weidong Yin, chairman, president and chief executive officer of the Company, and SAIF Partners IV L.P. and/or its affiliates will carefully consider and evaluate both proposals with] []

By | 2016-03-16T05:56:35+00:00 February 4th, 2016|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Receipt of Competing Non-Binding “Going Private”

[Sinovac Announces Receipt of Competing Non-Binding “Going Private” Proposal The special committee of the Company’s independent directors, which was formed to consider the preliminary non-binding proposal letter, dated January 30, 2016, from Mr. Weidong Yin, chairman, president and chief executive officer of the Company, and SAIF Partners IV L.P. and/or its affiliates will carefully consider and evaluate both proposals with] []

By | 2016-03-16T05:57:38+00:00 February 4th, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar